GERN Q3 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+17138.4% YoY

Gross Profit

$28M98.4% margin

Operating Income

-$28M-99.8% margin

Net Income

-$26M-93.5% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+3105.3%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$445M

Total Liabilities

$153M

Stockholders' Equity

$292M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$164,000	+17138.4%
Gross Profit	$28M	$164,000	+16860.4%
Operating Income	-$28M	-$48M	+40.7%
Net Income	-$26M	-$45M	+41.0%

Revenue Segments

Revenues Before Adjustments

$33M54%

Product

$28M46%